Resmed Inc
XMUN:RME
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
R
|
Resmed Inc
XMUN:RME
|
US |
|
Hateks Hatay Tekstil Isletmeleri AS
IST:HATEK.E
|
TR |
|
G
|
GN Store Nord A/S
F:GNN
|
DK |
|
B
|
Boeing Co
XHAM:BCO
|
US |
|
i3 Interactive Inc
OTC:BLITF
|
CA |
|
Alexander's Inc
F:AXE
|
US |
|
C
|
Cheniere Energy Inc
XMUN:CHQ1
|
US |
Wall St Price Targets
RME Price Targets Summary
Resmed Inc
According to Wall Street analysts, the average 1-year price target for RME is 205.11 EUR with a low forecast of 151.24 EUR and a high forecast of 287.51 EUR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is RME's stock price target?
Price Target
205.11
EUR
According to Wall Street analysts, the average 1-year price target for RME is 205.11 EUR with a low forecast of 151.24 EUR and a high forecast of 287.51 EUR.
What is the Revenue forecast for Resmed Inc?
Projected CAGR
6%
Over the last 14 years, the compound annual growth rate for Revenue has been 11%. The projected CAGR for the next 3 years is 6%.
What is the Gross Profit forecast for Resmed Inc?
Projected CAGR
7%
Over the last 14 years, the compound annual growth rate for Gross Profit has been 11%. The projected CAGR for the next 3 years is 7%.
What is the Operating Income forecast for Resmed Inc?
Projected CAGR
8%
Over the last 14 years, the compound annual growth rate for Operating Income has been 14%. The projected CAGR for the next 3 years is 8%.
What is the Pre-Tax Income forecast for Resmed Inc?
Projected CAGR
9%
Over the last 14 years, the compound annual growth rate for Pre-Tax Income has been 13%. The projected CAGR for the next 3 years is 9%.
What is the Net Income forecast for Resmed Inc?
Projected CAGR
9%
Over the last 14 years, the compound annual growth rate for Net Income has been 14%. The projected CAGR for the next 3 years is 9%.